GC Cell Corporation (KOSDAQ:144510)
South Korea · Delayed Price · Currency is KRW 13,600
+100 (0.74%)
Sep 1, 2026, 3:30 PM KST
GC Cell Market Cap
GC Cell has a market cap or net worth of 202.87 billion as of September 1, 2026. Its market cap has decreased by -28.38% in one year.
Market Cap
202.87B
Enterprise Value
313.51B
Revenue
162.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,600.00
ChartMarket Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 202.87B, a decrease of -60.04%. That is a compound annual growth rate of -8.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 202.87B | -45.67% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteina | 396.16B |
| SillaJen | 360.24B |
| MEDIPOST | 350.99B |
| Genomictree | 288.19B |
| NeoImmuneTech | 248.16B |
| Bioneer | 214.48B |
| HLB Therapeutics | 196.24B |
| Anterogen.Co.,Ltd. | 148.59B |